ARTICLE | Clinical News
Quilvax-M: Began Trials
July 26, 1999 7:00 AM UTC
Aquila Biopharmaceuticals Inc. (AQLA), Framingham, Mass. Product: Quilvax-M Business: Agbio/Veterinary/Environmental Therapeutic category: Immune stimulation Target: Staphylococcus aureus Indication: ...